Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Carolina Schinke

Concepts (322)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Myeloma
80
2025
3049
9.320
Why?
Antibodies, Bispecific
10
2025
94
3.810
Why?
B-Cell Maturation Antigen
9
2025
98
2.510
Why?
Hematopoietic Stem Cell Transplantation
8
2024
603
1.920
Why?
Bone Marrow
11
2024
364
1.340
Why?
Neoplasm, Residual
7
2025
173
1.330
Why?
Monoclonal Gammopathy of Undetermined Significance
5
2025
125
1.330
Why?
Leukemia, Plasma Cell
2
2020
33
1.300
Why?
Humans
95
2025
52483
1.280
Why?
Neoplasms, Plasma Cell
3
2024
37
1.260
Why?
Paraproteinemias
2
2022
74
1.250
Why?
Positron-Emission Tomography
5
2025
301
1.190
Why?
Immunotherapy, Adoptive
6
2024
166
1.140
Why?
Diffusion Magnetic Resonance Imaging
3
2025
133
1.080
Why?
Neoplasm Recurrence, Local
8
2025
649
1.070
Why?
Aged
29
2025
10121
1.010
Why?
Immunoglobulin Light Chains
2
2017
90
0.990
Why?
Prognosis
18
2025
2099
0.940
Why?
Transplantation, Autologous
9
2024
488
0.930
Why?
Immunoglobulins, Intravenous
1
2025
63
0.910
Why?
Gene Expression Regulation, Neoplastic
10
2024
857
0.900
Why?
Myelodysplastic Syndromes
5
2016
86
0.870
Why?
Immunoconjugates
2
2022
39
0.860
Why?
Mutation
8
2022
1347
0.850
Why?
Middle Aged
28
2025
13028
0.850
Why?
Antibodies, Monoclonal
6
2023
481
0.780
Why?
Male
36
2025
26761
0.760
Why?
Leukemia, Myeloid, Acute
4
2019
203
0.750
Why?
Gene Expression Profiling
11
2025
1105
0.750
Why?
Health Personnel
1
2024
256
0.730
Why?
Adult
24
2025
14161
0.730
Why?
Testis
1
2021
72
0.690
Why?
Signal Transduction
6
2024
1671
0.680
Why?
Aged, 80 and over
12
2025
3392
0.660
Why?
Tumor Microenvironment
5
2024
256
0.660
Why?
Hematopoietic Stem Cells
3
2019
187
0.650
Why?
Plasma Cells
6
2025
239
0.630
Why?
Quality of Life
1
2025
879
0.630
Why?
Cell Proliferation
8
2023
1023
0.620
Why?
Clonal Evolution
4
2024
58
0.620
Why?
Female
32
2025
28171
0.620
Why?
Gene Expression
3
2018
618
0.610
Why?
Clinical Trials as Topic
6
2023
467
0.550
Why?
Antineoplastic Combined Chemotherapy Protocols
5
2024
1031
0.550
Why?
Translocation, Genetic
5
2021
265
0.540
Why?
Thoracic Neoplasms
1
2016
13
0.510
Why?
Plasmacytoma
1
2016
43
0.490
Why?
Receptors, Interleukin-8B
1
2015
5
0.480
Why?
Survival Analysis
8
2024
673
0.470
Why?
Interleukin-8
1
2015
86
0.460
Why?
Receptors, G-Protein-Coupled
2
2024
56
0.430
Why?
Antineoplastic Agents
7
2024
1222
0.410
Why?
Combined Modality Therapy
4
2024
639
0.400
Why?
Fluorodeoxyglucose F18
5
2021
188
0.390
Why?
Neutropenia
2
2023
115
0.380
Why?
DNA Methylation
4
2020
592
0.370
Why?
Oncogene Proteins, Fusion
2
2018
61
0.370
Why?
Neoplasms, Second Primary
2
2024
77
0.370
Why?
Chromosomes, Human, Pair 1
3
2023
96
0.360
Why?
Polycomb Repressive Complex 2
2
2021
48
0.360
Why?
Stem Cell Transplantation
3
2022
185
0.350
Why?
Evolution, Molecular
2
2021
93
0.350
Why?
Epigenesis, Genetic
4
2020
406
0.340
Why?
Tretinoin
1
2010
54
0.330
Why?
Treatment Outcome
10
2025
5422
0.320
Why?
Cell Line, Tumor
7
2024
1470
0.320
Why?
Risk Assessment
4
2024
1327
0.310
Why?
Transcription Factors
3
2023
566
0.310
Why?
Transcriptome
3
2025
370
0.310
Why?
Immunoglobulin kappa-Chains
2
2021
22
0.310
Why?
Disease Progression
8
2025
871
0.300
Why?
DNA-Binding Proteins
2
2021
422
0.280
Why?
Neoplasm Proteins
3
2020
334
0.280
Why?
Melanoma
1
2010
288
0.270
Why?
RANK Ligand
2
2024
187
0.250
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
2024
91
0.250
Why?
Biopsy
2
2018
605
0.240
Why?
Radiopharmaceuticals
3
2021
204
0.230
Why?
Skin Neoplasms
1
2010
505
0.230
Why?
Chemokine CCL3
1
2024
13
0.230
Why?
HMGB1 Protein
1
2024
21
0.230
Why?
Retrospective Studies
7
2025
6607
0.230
Why?
Dexamethasone
3
2024
438
0.230
Why?
T-Lymphocytes
5
2024
340
0.220
Why?
Kaplan-Meier Estimate
3
2021
483
0.220
Why?
Chemokine CXCL12
1
2024
32
0.220
Why?
Sialic Acid Binding Ig-like Lectin 2
1
2024
2
0.220
Why?
Antigens, CD19
1
2024
28
0.220
Why?
Mutation Rate
2
2021
36
0.210
Why?
Bone Resorption
2
2024
302
0.210
Why?
Recurrence
6
2025
672
0.210
Why?
Genome-Wide Association Study
1
2024
186
0.210
Why?
Myeloproliferative Disorders
1
2023
31
0.210
Why?
Cell Cycle
2
2021
230
0.210
Why?
Neoplasm Staging
2
2024
772
0.200
Why?
Genomics
2
2023
268
0.200
Why?
Proto-Oncogene Proteins B-raf
2
2020
81
0.190
Why?
Drug Resistance, Neoplasm
1
2024
326
0.190
Why?
Osteolysis
1
2022
75
0.190
Why?
Qualitative Research
1
2024
364
0.190
Why?
Drug Approval
1
2022
46
0.190
Why?
Waldenstrom Macroglobulinemia
1
2022
40
0.190
Why?
Lymphoma, B-Cell
1
2022
61
0.190
Why?
Osteocytes
1
2024
226
0.190
Why?
Bone Marrow Transplantation
1
2022
113
0.190
Why?
Hematologic Diseases
1
2021
21
0.180
Why?
Polymorphism, Single Nucleotide
1
2024
505
0.180
Why?
Epigenomics
1
2021
75
0.180
Why?
Patient Participation
1
2022
69
0.180
Why?
Genetic Predisposition to Disease
1
2024
528
0.180
Why?
Abnormal Karyotype
1
2021
6
0.180
Why?
Chromosome Deletion
2
2023
142
0.180
Why?
Mice
6
2024
5949
0.180
Why?
Drug Design
2
2013
120
0.180
Why?
Myeloma Proteins
1
2021
26
0.180
Why?
Immunoglobulin A
1
2021
45
0.180
Why?
Risk Factors
8
2024
3889
0.180
Why?
Communicable Diseases
1
2021
55
0.170
Why?
Antibodies, Monoclonal, Humanized
1
2022
236
0.170
Why?
Genes, Tumor Suppressor
2
2021
74
0.170
Why?
Gene Expression Regulation, Leukemic
1
2020
32
0.170
Why?
Hematologic Neoplasms
1
2022
106
0.170
Why?
Salvage Therapy
1
2021
136
0.170
Why?
Immunoglobulin G
1
2021
195
0.170
Why?
Practice Guidelines as Topic
1
2023
488
0.170
Why?
Exosome Multienzyme Ribonuclease Complex
1
2020
12
0.170
Why?
Neoplasm Invasiveness
1
2021
278
0.160
Why?
Bone Diseases
1
2021
96
0.160
Why?
Gene Amplification
1
2019
58
0.160
Why?
Chromosomal Instability
1
2019
16
0.160
Why?
Hematopoiesis, Extramedullary
1
2019
9
0.160
Why?
Gene Regulatory Networks
1
2020
111
0.160
Why?
Atrial Fibrillation
1
2022
200
0.160
Why?
Insulin-Like Growth Factor Binding Protein 2
1
2018
10
0.150
Why?
United States
3
2024
5192
0.150
Why?
Comorbidity
1
2021
625
0.150
Why?
Models, Statistical
1
2020
230
0.150
Why?
Sulfonamides
1
2019
133
0.150
Why?
Healthcare Disparities
1
2022
299
0.150
Why?
Spleen
1
2019
172
0.150
Why?
Animals
8
2024
13505
0.150
Why?
Spinal Fractures
1
2018
38
0.150
Why?
Phosphotransferases
1
2018
17
0.150
Why?
Bacteremia
1
2019
92
0.140
Why?
Adipocytes
1
2018
132
0.140
Why?
Cell Differentiation
3
2022
665
0.140
Why?
Gene Rearrangement
1
2018
75
0.140
Why?
Disease-Free Survival
4
2019
460
0.140
Why?
Kidney Function Tests
1
2017
54
0.140
Why?
Hexokinase
1
2017
16
0.140
Why?
Chromosomes, Human, Pair 17
1
2017
35
0.140
Why?
Calcification, Physiologic
1
2017
42
0.130
Why?
Glomerular Filtration Rate
1
2017
124
0.130
Why?
Survival Rate
4
2020
945
0.130
Why?
Chromosome Aberrations
2
2023
297
0.130
Why?
Pelvis
1
2017
69
0.130
Why?
Histoplasma
1
2016
24
0.130
Why?
CA-125 Antigen
1
2016
16
0.130
Why?
HIV Infections
1
2021
389
0.130
Why?
Receptor, TIE-2
1
2016
16
0.130
Why?
Cardiomyopathy, Restrictive
1
2016
5
0.130
Why?
Histoplasmosis
1
2016
47
0.130
Why?
Urea
1
2016
82
0.130
Why?
Indazoles
1
2016
47
0.130
Why?
p38 Mitogen-Activated Protein Kinases
1
2016
94
0.130
Why?
Gene Expression Regulation, Enzymologic
1
2017
179
0.120
Why?
Remission Induction
3
2024
218
0.120
Why?
Gastrointestinal Diseases
1
2016
125
0.120
Why?
Tumor Suppressor Protein p53
1
2017
221
0.120
Why?
Proteasome Inhibitors
1
2016
104
0.120
Why?
Immunologic Factors
1
2016
117
0.120
Why?
Cell Cycle Checkpoints
1
2015
32
0.120
Why?
Kidney Diseases
1
2017
220
0.120
Why?
Time Factors
2
2021
2968
0.120
Why?
Cluster Analysis
1
2015
233
0.110
Why?
Xenograft Model Antitumor Assays
1
2015
220
0.110
Why?
Myocardium
1
2017
453
0.110
Why?
Thrombopoiesis
1
2014
5
0.110
Why?
Hydrazines
1
2014
17
0.110
Why?
Benzoates
1
2014
21
0.110
Why?
Neoplastic Stem Cells
1
2015
99
0.110
Why?
Immunotherapy
1
2016
244
0.110
Why?
Cystatin M
2
2024
19
0.110
Why?
Disease Models, Animal
2
2016
1478
0.100
Why?
Cell Survival
1
2015
612
0.100
Why?
Pyrazoles
1
2014
114
0.100
Why?
Cross-Sectional Studies
3
2023
1678
0.100
Why?
Chromosomes, Human, Pair 7
1
2012
30
0.100
Why?
Clone Cells
2
2023
77
0.100
Why?
STAT3 Transcription Factor
1
2012
85
0.100
Why?
Cardiovascular Diseases
1
2017
490
0.100
Why?
Chromatin
2
2024
139
0.090
Why?
Cell Transformation, Neoplastic
1
2013
184
0.090
Why?
Thalidomide
1
2014
377
0.090
Why?
Follow-Up Studies
3
2024
2279
0.090
Why?
Flow Cytometry
2
2012
478
0.090
Why?
In Situ Hybridization, Fluorescence
2
2023
263
0.090
Why?
Leukemia, Promyelocytic, Acute
1
2010
12
0.090
Why?
Luciferases
1
2010
48
0.080
Why?
Response Elements
1
2010
29
0.080
Why?
Gene Silencing
1
2010
118
0.080
Why?
Alleles
2
2021
276
0.080
Why?
Tumor Burden
2
2020
136
0.080
Why?
Transfection
1
2010
357
0.080
Why?
Recombinant Fusion Proteins
1
2010
177
0.080
Why?
Molecular Structure
1
2010
314
0.080
Why?
Histones
2
2021
314
0.080
Why?
Apoptosis
2
2014
1119
0.080
Why?
DNA Copy Number Variations
2
2021
117
0.070
Why?
Syndecan-1
2
2021
74
0.070
Why?
Case-Control Studies
2
2024
1201
0.060
Why?
Tumor Cells, Cultured
2
2020
460
0.060
Why?
Imaging, Three-Dimensional
2
2017
154
0.060
Why?
Gene Expression Regulation
1
2010
990
0.060
Why?
Transmembrane Activator and CAML Interactor Protein
1
2024
6
0.060
Why?
Mendelian Randomization Analysis
1
2024
7
0.060
Why?
ROC Curve
1
2025
253
0.060
Why?
Telomere
1
2024
38
0.060
Why?
Arkansas
2
2021
2028
0.060
Why?
Mitogen-Activated Protein Kinase Kinases
1
2024
34
0.060
Why?
Ferritins
1
2024
36
0.050
Why?
Killer Cells, Natural
1
2024
116
0.050
Why?
Myeloid Progenitor Cells
1
2023
17
0.050
Why?
X-Ray Microtomography
1
2024
79
0.050
Why?
CD8-Positive T-Lymphocytes
1
2024
132
0.050
Why?
Antibodies
1
2024
159
0.050
Why?
Receptors, Antigen, T-Cell
1
2023
54
0.050
Why?
Demography
1
2023
90
0.050
Why?
B-Lymphocytes
1
2024
184
0.050
Why?
Cell Communication
1
2023
71
0.050
Why?
TNF Receptor-Associated Factor 3
1
2022
13
0.050
Why?
Neoplasms
1
2013
1325
0.050
Why?
Patients
1
2022
51
0.050
Why?
Geography
1
2022
65
0.050
Why?
Myeloid Differentiation Factor 88
1
2022
34
0.050
Why?
Patient Selection
1
2023
259
0.050
Why?
United States Food and Drug Administration
1
2022
98
0.050
Why?
Oncogenes
1
2021
60
0.050
Why?
Infant
1
2010
3733
0.050
Why?
Phylogeny
1
2022
231
0.050
Why?
Tomography, X-Ray Computed
2
2017
1165
0.050
Why?
SOXC Transcription Factors
1
2021
13
0.040
Why?
Transcriptional Activation
1
2021
122
0.040
Why?
Lymphoma, Large B-Cell, Diffuse
1
2022
106
0.040
Why?
Pyrimidines
1
2022
199
0.040
Why?
Cyclin D2
1
2020
21
0.040
Why?
Proto-Oncogene Proteins p21(ras)
1
2021
69
0.040
Why?
Aneuploidy
1
2020
18
0.040
Why?
Proto-Oncogene Proteins c-maf
1
2020
19
0.040
Why?
Chromosomes, Human, Pair 4
1
2020
30
0.040
Why?
ras Proteins
1
2020
64
0.040
Why?
Histone Code
1
2020
32
0.040
Why?
Cyclin D1
1
2020
57
0.040
Why?
Chromosomes, Human, Pair 11
1
2020
55
0.040
Why?
Genome, Human
1
2021
121
0.040
Why?
Chromosomes, Human, Pair 14
1
2020
75
0.040
Why?
Protein Kinase Inhibitors
1
2022
227
0.040
Why?
DNA, Neoplasm
1
2020
146
0.040
Why?
DNA Mutational Analysis
1
2020
180
0.040
Why?
Genetic Variation
1
2020
230
0.040
Why?
Osteoclasts
1
2022
428
0.040
Why?
Health Status Disparities
1
2022
215
0.040
Why?
Multivariate Analysis
1
2021
591
0.040
Why?
High-Throughput Nucleotide Sequencing
1
2020
182
0.040
Why?
Computational Biology
1
2020
212
0.040
Why?
Gram-Positive Bacterial Infections
1
2019
30
0.040
Why?
Pseudomonas Infections
1
2019
54
0.040
Why?
Syndrome
1
2019
247
0.040
Why?
Fractures, Compression
1
2018
17
0.040
Why?
Randomized Controlled Trials as Topic
1
2021
595
0.040
Why?
Promoter Regions, Genetic
1
2020
467
0.040
Why?
Receptor Protein-Tyrosine Kinases
1
2018
52
0.040
Why?
Protein-Tyrosine Kinases
1
2018
87
0.040
Why?
False Positive Reactions
1
2017
63
0.030
Why?
Bone and Bones
1
2021
494
0.030
Why?
Amino Acid Sequence
1
2018
578
0.030
Why?
Itraconazole
1
2016
38
0.030
Why?
beta-Glucans
1
2016
23
0.030
Why?
Alkaline Phosphatase
1
2017
94
0.030
Why?
Databases, Factual
1
2020
706
0.030
Why?
Genes, ras
1
2016
43
0.030
Why?
Angiopoietin-1
1
2016
16
0.030
Why?
Amphotericin B
1
2016
103
0.030
Why?
Genes, p53
1
2016
52
0.030
Why?
Ileum
1
2016
88
0.030
Why?
NF-kappa B
1
2018
322
0.030
Why?
Intestinal Obstruction
1
2016
38
0.030
Why?
Glycolysis
1
2016
73
0.030
Why?
Gene Knockdown Techniques
1
2016
108
0.030
Why?
Colonoscopy
1
2016
108
0.030
Why?
Models, Genetic
1
2016
169
0.030
Why?
Genomic Instability
1
2016
89
0.030
Why?
Fever
1
2016
112
0.030
Why?
Drug Screening Assays, Antitumor
1
2016
136
0.030
Why?
Image Interpretation, Computer-Assisted
1
2016
107
0.030
Why?
Staphylococcal Infections
1
2019
285
0.030
Why?
Logistic Models
1
2018
925
0.030
Why?
Phosphatidylinositol 3-Kinases
1
2016
151
0.030
Why?
Heart
1
2017
345
0.030
Why?
Proportional Hazards Models
1
2016
443
0.030
Why?
Algorithms
1
2018
672
0.030
Why?
Echocardiography
1
2017
415
0.030
Why?
Weight Loss
1
2016
248
0.030
Why?
Megakaryocyte Progenitor Cells
1
2014
1
0.030
Why?
Young Adult
1
2024
4329
0.030
Why?
Antifungal Agents
1
2016
347
0.030
Why?
Longitudinal Studies
1
2016
747
0.030
Why?
Models, Immunological
1
2013
8
0.030
Why?
Chemistry, Pharmaceutical
1
2013
35
0.030
Why?
Early Diagnosis
1
2013
95
0.020
Why?
Karyotyping
1
2012
78
0.020
Why?
Azacitidine
1
2012
39
0.020
Why?
Primary Cell Culture
1
2012
62
0.020
Why?
Cell Lineage
1
2012
85
0.020
Why?
Polymerase Chain Reaction
1
2013
461
0.020
Why?
Child
1
2024
7248
0.020
Why?
Antigens, CD
1
2012
218
0.020
Why?
Enzyme Inhibitors
1
2013
372
0.020
Why?
Magnetic Resonance Imaging
1
2017
1546
0.020
Why?
Cytokines
1
2013
623
0.020
Why?
Reproducibility of Results
1
2013
1229
0.020
Why?
Cohort Studies
1
2013
1542
0.020
Why?
Schinke's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description